Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linzyme Biosciences is a high-tech biotechnology company headquartered in Ningbo, China, that specializes in the engineering and production of high-end enzymes. The company utilizes a proprietary directed evolution and high-throughput screening platform to develop enzymes for molecular diagnostics, next-generation sequencing (NGS), and biopharmaceutical manufacturing. Their product portfolio includes critical components for mRNA vaccine production, such as T7 RNA polymerase and various capping enzymes, as well as high-fidelity DNA polymerases for research applications. In addition to its catalog of off-the-shelf reagents, Linzyme provides contract development and manufacturing (CDMO) services for customized protein expression and enzyme optimization. The company serves a global clientele across the IVD, life science research, and pharmaceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Linzyme Biosciences.